prulifloxacin has been researched along with Recrudescence in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bini, V; Costantini, E; Di Biase, M; Frumenzio, E; Giovannozzi, S; Maglia, D; Salvini, E | 1 |
Bini, V; Cicalese, A; Costantini, E; Filocamo, MT; Lazzeri, M; Li Marzi, V; Salvini, E; Zucchi, A | 1 |
Busetto, GM; De Berardinis, E; De Cobelli, O; Del Giudice, F; Ferro, M; Gentile, V; Giovannone, R; Matei, DV; Tricarico, S | 1 |
Blasi, F; Bonizzoni, E; Campanini, M; Casali, A; Colagrande, P; Giusti, M; Gussoni, G; Iori, I; Mazzone, A; Politi, C; Sgambato, F; Valerio, A | 1 |
Bartoletti, R; Boddi, V; Cai, T; Mazzoli, S; Mondaini, N; Nesi, G | 1 |
4 trial(s) available for prulifloxacin and Recrudescence
Article | Year |
---|---|
Prulifloxacin vs fosfomycin for prophylaxis in female patients with recurrent UTIs: a non-inferiority trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Dioxolanes; Female; Fluoroquinolones; Fosfomycin; Humans; Middle Aged; Piperazines; Recurrence; Treatment Outcome; Urinary Tract Infections | 2014 |
Chronic bacterial prostatitis: efficacy of short-lasting antibiotic therapy with prulifloxacin (Unidrox®) in association with saw palmetto extract, lactobacillus sporogens and arbutin (Lactorepens®).
Topics: Adult; Anti-Bacterial Agents; Arbutin; Bacterial Infections; Chronic Disease; Combined Modality Therapy; Dietary Supplements; Dioxolanes; Drug Administration Schedule; Fluoroquinolones; Humans; Lactobacillus; Male; Middle Aged; Piperazines; Plant Extracts; Prostatitis; Recurrence; Serenoa; Young Adult | 2014 |
Prulifloxacin vs Levofloxacin for Exacerbation of COPD after Failure of Other Antibiotics.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Dioxolanes; Disease Progression; Female; Fluoroquinolones; Follow-Up Studies; Humans; Levofloxacin; Male; Piperazines; Pulmonary Disease, Chronic Obstructive; Recurrence; Retreatment; Single-Blind Method; Symptom Assessment; Symptom Flare Up; Treatment Failure | 2016 |
14-day prulifloxacin treatment of acute uncomplicated cystitis in women with recurrent urinary tract infections: a prospective, open-label, pilot trial with 6-month follow-up.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Bacteria; Cystitis; Dioxolanes; Female; Fluoroquinolones; Follow-Up Studies; Humans; Middle Aged; Pilot Projects; Piperazines; Prospective Studies; Quality of Life; Recurrence; Treatment Outcome; Urinary Tract Infections; Urine; Vagina; Young Adult | 2009 |
1 other study(ies) available for prulifloxacin and Recrudescence
Article | Year |
---|---|
Role of phytotherapy associated with antibiotic prophylaxis in female patients with recurrent urinary tract infections.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Combined Modality Therapy; Dioxolanes; Female; Fluoroquinolones; Fosfomycin; Humans; Middle Aged; Phytotherapy; Piperazines; Recurrence; Retrospective Studies; Urinary Tract Infections | 2013 |